News & Events

News

This is our Epistem News section, for corporate news please visit our parent company, genedrive plc.

 

Epistem lines up £2.5m cornerstone investor

Tuesday June 07, 2016

Manchester-headquartered biotechnology company Epistem has lined up a £2.5m cornerstone investor to

Upcoming Webinar to Examine Pre-Clinical Models of Intestinal Toxicity

Tuesday May 24, 2016

/EINPresswire.com/ -- TORONTO, ON--(Marketwired - May 24, 2016) - On Friday, June 10, 2016, at 10am EDT (3pm BST/UK), Xtalks will host a complimentary webinar featuring Cath Booth, Co-Founder and Managing Director of Contract Research Services at Epistem as the keynote speaker.

Epistem's diagnostic test scores well in hepatitis trial

Tuesday May 03, 2016

Epistem Holdings Plc’s (LON:EHP) rapid diagnostic system Genedrive has performed well in

Epistem funding from US Department of Defense

Monday March 21, 2016

StockMarketWire.com - The US Department of Defense has awarded Epistem $2.9m in funding for the next phase of its

Epistem makes progress on two diagnostic fronts

Monday February 22, 2016

(MENAFN - ProactiveInvestors - UK) To get a new technology accepted is never easy but Epistem (LON:EHP) is making progress on two fronts with its Genedrive diagnostic platform. A test for Hepatitis C (HCV) has just been cleared for clinical trials by the Institut Pasteur in Paris.

Update on CEO Appointment

Friday February 19, 2016

RNS Press Release For release: 19 February 2016 Update on CEO Appointment Epistem Holdings Plc (LSE: EHP), the

Epistem Says First Test On Hepatitis C Test Completed Successfully

Thursday February 18, 2016

LONDON (Alliance News) - Personalised medicine and biotechnology company

Epistem diagnostic test cleared for Hepatitis C trials

Thursday February 18, 2016

Epistem Holdings’ (LON:EHP) genedrive diagnostic test has been cleared for clinical trials in

Epistem Appoints David Budd as Chief Executive Officer

Wednesday January 13, 2016

MANCHESTER, England, January 13, 2016 /PRNewswire/ -- Epistem Holdings Plc (LSE: EHP), the

Epistem Appoints David Budd as Chief Executive Officer

Wednesday January 13, 2016

MANCHESTER, England, January 13, 2016 /PRNewswire/ -- Epistem Holdings Plc (EHP.L), the personalised medicine and biotechnology company, is pleased to announce the appointment of David Budd as Chief Executive Officer and as a Director of Epistem.

U.S. Department of Defense to Fund Research at Indiana University and Epistem UK Investigating Treatments for Radiation Sickness - Press Release - Digital Journal

Wednesday November 11, 2015

U.S. Department of Defense to Fund Research at Indiana University and Epistem UK Investigating Treatments for Radiation Sickness

Wednesday November 11, 2015

© 2016-17 Epistem Ltd. : : last modified: 21 Jul 2016

Epistem Ltd is a division of genedrive plc